Clinical trial
Subject Preference for Scalp Psoriasis Treatment
NCT00438399 · Galderma R&D, Industry · Completed
Key facts
| NCT number | NCT00438399 |
|---|---|
| Title | Subject Preference for Scalp Psoriasis Treatment |
| Official title | Subject Preference Comparison Between Clobetasol Propionate Shampoo, 0.05% and Three Other Topical Corticosteroids in the Treatment of Moderate to Severe Scalp Psoriasis |
| Lead sponsor | Galderma R&D, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Scalp Psoriasis |
| Intervention type | Drug |
| Interventions | C. propionate - Corticosteroid 1, C. propionate- Corticosteroid 2, C. propionate -Corticosteroid 3, Corticosteroid 1- C. propionate, Corticosteroid 2 - C. propionate, Corticosteroid 3 - C. propionate |
| Enrollment | 219 |
| Start date | Feb 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Feb 22, 2007 |
| Last update posted | Feb 18, 2021 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: